Online Injury Attorney

Following the July Safety warning in which the incidence of adverse reactions to vaginal mesh implants was upgraded from “rare” and “serious concern” was expressed the FDA met the US manufacturers of vaginal mesh in Maryland on 9 September.

While the mesh has been used for over thirty years than three decades, mainly for hernias, its application has recently been evolved and one of the uses most now of concern is the transvaginal surgical mesh. The FDA reckons that, as manufacturers expanded surgical mesh for these additional applications, none of the mesh has been evaluated for clinical data.

The mesh was licensed for use as a vaginal implant under an FDA ruling 510(k) which allows a product which is already successfully used to be applied elsewhere as it is essentially the same. This ruling has now been called into question in this case. There are some calls for the device to be reclassified as “High Risk”
If the FDA reclassifies the implants as “High Risk”, it will require data on risks and effectiveness before new models can go on sale. The panel also recommended post-marketing studies to gather long- term data on products already on the market.
The FDA would also specify and control the clinical trials to test the devices which must last at least three years. There are also suggestions of a registry being created to follow patients who already possess implants.

The added regulation for high-risk devices could harm patients by slowing progress of improved implants. In recent years the improvement to the mesh has been remarkable and if burdened by bureaucracy and 3 year clinical trials the improvements would slow. The manufacturers contend that they did clinical trials and the devices are safe. They also contend that recall is impractical. Some groups have contended that the FDA ought go beyond new studies and recall mesh implants on the market now

At the meeting in Maryland, surgeons representing three health societies said clinical trials have shown mesh works well for treating with incontinence. New devices must nonetheless undergo premarket testing to get FDA approval and the surgeons need better training as key to the reduction of adverse results from the product’s implantation. In the interim the manufacturers face a California Vaginal Mesh Lawsuit as a mass tort action in that it is contended that there is harm caused by the failure of the product.

Such harm is pretty horrific as the major complaint is erosion, the wearing away of the tissue resulting in the mesh itself protruding into the vagina, In addition, or instead of a great deal of pain and discomfort may be felt. The onset of infections and bleeding, incontinence and bowel problems as well as the inability to have sexual intercourse without pain are all typical symptoms of the failure of the device.

Anyone who has had a vaginal mesh implant in the last 10 years and is experiencing any of the symptoms mentioned above should consult with a California Vaginal Mesh Attorney to see if they are eligible to partake in the mass tort action already in preparation.